Skip to main content
SpringerLink
Log in

Autoimmunerkrankungen bei Typ 1 Diabetes

Autoimmune diseases in type 1 diabetes

  • leitlinien für die praxis
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Bis zu 30 % der Typ 1 Diabetiker entwickeln entsprechend Literaturangaben weitere Autoimmunerkrankungen. Zu den häufigsten Formen zählen dabei die Autoimmunthyroiditis mit 15‒30 %, die Autoimmungastritis mit 5‒10 %, die Zöliakie mit 4‒9 % und Vitiligo mit 2‒10 %. Deutlich seltener findet sich ein Morbus Addison. Die diagnostischen Maßnahmen im Rahmen der Diabetikerbetreuung sollten deshalb Screeninguntersuchungen auf weitere Autoimmunerkrankungen beinhalten.

Summary

According to literature about 30 % of the patients with type 1 diabetes develop further autoimmune diseases. Thyroid dysfunction represents with 15‒30 % the most common disorder, followed by gastritis with 5‒10 %, celiac disease with 4‒9 % and vitiligo with 2‒10 %. Addison’s disease seems to be less prevalent. Diagnostic procedures in the course of the comprehensive care for diabetic patients should therefore include screening for further autoimmune diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type 1 assigned to chromosome 21. Nat Genet. 1994;8:83–7.

    Article  CAS  PubMed  Google Scholar 

  2. ADA. Standards of medical care in diabetes – 2015. Diabetes Care. 2015;S1:S8–16.

    Google Scholar 

  3. Barker JM, Yu J, Yu L, et al. Autoantibody „subspecificity“ in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care. 2005;28:850–5.

    Article  CAS  PubMed  Google Scholar 

  4. Betterle C, Scalici C, Presotto F, et al. The natural history of adrenal function in autoimmen patients with adrenal autoantibodies. J Endocrinol. 1988;117:467–75.

    Article  CAS  PubMed  Google Scholar 

  5. DeBlock C, de Leeuw I, Bogers J, et al. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care. 2003;26:82–8.

    Article  Google Scholar 

  6. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004;350:2068–79.

    Article  CAS  PubMed  Google Scholar 

  7. Gawkrodger DJ, Ormerod AD, Shaw L, et al. Guideline fort he diagnosis and management of vitilio. Br J Dermatol. 2008;159:1051–76.

    Article  CAS  PubMed  Google Scholar 

  8. Heukamp I, Then C, Lechner A, Seissler J. Update Typ-1-Diabetes. Internist 203(54):201–16.

  9. Hogg-Kollars S, Al Dulaimi D, Tait K, Rostami K. Type 1 diabetes mellitus and gluten induced disorders. Gastroenterol Hepatol Bed Bench. 2014;7:189–97.

    PubMed  PubMed Central  Google Scholar 

  10. Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, Holl RW, Donaghue KC. Other complications and associated conditions. ISPAD Clinical Practice Consensus Guidelines 2006–2007. Pediatr Diabetes. 2007;8:171–6.

    Article  PubMed  Google Scholar 

  11. Lampasona V, Bonfanti R, Bazzigaluppi E, et al. Antibodies to tissue transglutaminase C in type 1 diabetes. Diabetologia. 1999;42:1195–8.

    Article  CAS  PubMed  Google Scholar 

  12. Schober E, Bittmann B, Granditsch G, Huber VVD, Hüppe A, Jäger A, Oberhuber G, Rami B, Reichel G. Screening by enti-endomysium antibody for celiac disease in diabetic children and adolescents in Austria. J Pediatr Gastroenterol Nute. 2000;30:391–6.

    Article  CAS  Google Scholar 

  13. Schott M, Seissler J. Autoimmune polyendocrine syndromes. In: Renz H, Herausgeber. Autoimmune diagnsotics. Berlin: De Gruyter; 2012. S. 177–89.

    Google Scholar 

  14. Shun CB, Donaghue KC, Phelan H, Twigg SM, Craig ME. Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis. Diabet Med. 2014;31:126–35.

    Article  CAS  PubMed  Google Scholar 

  15. Triolo TM, Armstrong TK, McFann K, Yu L, Rewers MJ, Klingensmith GJ, Eisenbarth GS, Barker JM. Additional autoimmune disease found in 33 % of patients at type 1 diabetes onset. Diabetes Care. 2011;34:1211–3.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Umipierrez GE, Latif KA, Murphy MB, et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care. 2003;26:1181–5.

    Article  Google Scholar 

  17. Valletta E, Fornaro M, Pecori S, Zanoni G. Selective immunoglobulin A deficiency and celiac disease: let’s give serology a chance. J Investiq Allergol Clin Immunol. 2011;21:242–4.

    CAS  Google Scholar 

  18. Van den Driessche A, Eenkhoorn V, Van Gaal L, De Block C. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med. 2009;67:376–87.

    PubMed  Google Scholar 

  19. Ziegler G, Rewers M, Simell O, et al. Seroconversion to multiple islet eutoantibodies and risk of progression to diabetes in children. JAMA. 2013;309:2473–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Interne Abteilung, Landeskrankenhaus Hochzirl - Natters, Hochzirl, Österreich

    Monika Lechleitner

  2. Interne Abteilung, Krankenhaus der Barmherzigen Brüder Salzburg, Salzburg, Österreich

    Friedrich Hoppichler

  3. Universitätsklinik für Innere Medizin, Medizinische Universität Innsbruck, Innsbruck, Österreich

    Susanne Kaser

Authors
  1. Monika Lechleitner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Friedrich Hoppichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susanne Kaser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika Lechleitner.

Ethics declarations

Interessenkonflikt

M. Lechleitner, F. Hoppichler und S. Kaser geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lechleitner, M., Hoppichler, F. & Kaser, S. Autoimmunerkrankungen bei Typ 1 Diabetes. Wien Klin Wochenschr 128 (Suppl 2), 201–203 (2016). https://doi.org/10.1007/s00508-015-0929-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-015-0929-x

Schlüsselwörter

Keywords

Search

Navigation